Molecular detection of PPARγ rearrangements and thyroid carcinoma in preoperative fine-needle aspiration biopsies (Endocrine Pathology (2008) 19 (166-174) (DOI: 10.1007/s12022-008-9036-0));Molecular detection of PPARγ rearrangements and thyroid carcinoma in preoperative fine-needle aspiration biopsies

Endocrine Pathology

Volumn 19, Issue 3, 2008, Pages 166-174

  French, Christopher A ^a   Fletcher, Jonathan A ^a   Cibas, Edmund S ^a   Caulfield, Christopher ^b   Allard, Paulette ^b   Kroll, Todd G ^c,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Chicago   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

Fine needle aspiration biopsy; Molecular diagnosis; Mutation; PPAR rearrangements; Thyroid cancer

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER MORPHOLOGY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICLE CYST; FOLLICULAR CARCINOMA; FOLLOW UP; GENE MUTATION; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NEEDLE BIOPSY; PAPILLARY CARCINOMA; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; THYROID CARCINOMA; THYROID TUMOR; THYROIDECTOMY; TUMOR CELL; ADENOCARCINOMA; GENETICS; MIDDLE AGED; PATHOLOGY;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; BIOPSY, FINE-NEEDLE; FEMALE; GENE REARRANGEMENT; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; PPAR GAMMA; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 58149235362     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12022-008-9053-z     Document Type: Erratum

References (65)

1. GH Tan H Gharib 1997 Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging Ann Intern Med 126 226 31
2. S Ezzat DA Sarti DR Cain GD Braunstein 1994 Thyroid incidentalomas. Prevalence by palpation and ultrasonography Arch Intern Med 154 1838 40
3. JN Bruneton C Balu-Maestro PY Marcy P Melia MY Mourou 1994 Very high frequency (13 mhz) ultrasonographic examination of the normal neck: Detection of normal lymph nodes and thyroid nodules J Ultrasound Med 13 87 90
4. DeLellis R, Lloyd R, Heitz P, Eng C. (eds.) Pathology and genetics of tumours of endocrine organs. Lyon: IARC Press pp. 49-133, 2004.
5. AA Renshaw EW Gould 2002 Why there is the tendency to "overdiagnose" the follicular variant of papillary thyroid carcinoma Am J Clin Pathol 117 19 21
6. JK Chan 2002 Strict criteria should be applied in the diagnosis of encapsulated follicular variant of papillary thyroid carcinoma Am J Clin Pathol 117 16 8
7. E Saxen K Franssila O Bjarnason T Normann N Ringertz 1978 Observer variation in histologic classification of thyroid cancer Acta Pathol Microbiol Scand [A] 86A 483 6
8. M Hirokawa JA Carney JR Goellner RA DeLellis CS Heffess R Katoh M Tsujimoto K Kakudo 2002 Observer variation of encapsulated follicular lesions of the thyroid gland Am J Surg Pathol 26 1508 14
9. ZW Baloch VA Livolsi 2002 Follicular-patterned lesions of the thyroid: The bane of the pathologist Am J Clin Pathol 117 143 50
10. RV Lloyd LA Erickson MB Casey KY Lam CM Lohse SL Asa JK Chan RA DeLellis HR Harach K Kakudo VA LiVolsi J Rosai TJ Sebo M Sobrinho-Simoes BM Wenig ME Lae 2004 Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma Am J Surg Pathol 28 1336 40
11. L Davies HG Welch 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002 Jama 295 2164 7
12. NC Hodgson J Button CC Solorzano 2004 Thyroid cancer: is the incidence still increasing Ann Surg Oncol 11 1093 7
13. H Gharib JR Goellner 1993 Fine-needle aspiration biopsy of the thyroid: an appraisal Ann Intern Med 118 282 9
14. B Hamberger H Gharib LJ Melton 3rd JR Goellner AR Zinsmeister 1982 Fine-needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care Am J Med 73 381 4
15. CS Grant ID Hay IR Gough PM McCarthy JR Goellner 1989 Long-term follow-up of patients with benign thyroid fine-needle aspiration cytologic diagnoses Surgery 106 980 5
16. M Santoro F Carlomagno ID Hay MA Herrmann M Grieco R Melillo MA Pierotti I Bongarzone G Della Porta N Berger 1992 Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype J Clin Invest 89 1517 22
17. A Greco C Miranda S Pagliardini L Fusetti I Bongarzone MA Pierotti 1997 Chromosome 1 rearrangements involving the genes tpr and ntrk1 produce structurally different thyroid-specific trk oncogenes Genes Chromosomes Cancer 19 112 23
18. A Fusco M Grieco M Santoro MT Berlingieri S Pilotti MA Pierotti G Della Porta G Vecchio 1987 A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases Nature 328 170 2
19. M Grieco M Santoro MT Berlingieri RM Melillo R Donghi I Bongarzone MA Pierotti G Della Porta A Fusco G Vecchio 1990 Ptc is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas Cell 60 557 63
20. HM Rabes EP Demidchik JD Sidorow E Lengfelder C Beimfohr D Hoelzel S Klugbauer 2000 Pattern of radiation-induced ret and ntrk1 rearrangements in 191 post-chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications Clin Cancer Res 6 1093 103
21. YE Nikiforov JM Rowland KE Bove H Monforte-Munoz JA Fagin 1997 Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children Cancer Res 57 1690 4
22. L Yip GJ Cote SE Shapiro GD Ayers CE Herzog RV Sellin SI Sherman RF Gagel JE Lee DB Evans 2003 Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship Arch Surg 138 409 16
23. LM Mulligan JB Kwok CS Healey MJ Elsdon C Eng E Gardner DR Love SE Mole JK Moore L Papi 1993 Germ-line mutations of the ret proto-oncogene in multiple endocrine neoplasia type 2a Nature 363 458 60
24. H Donis-Keller S Dou D Chi KM Carlson K Toshima TC Lairmore JR Howe JF Moley P Goodfellow SA Wells Jr 1993 Mutations in the ret proto-oncogene are associated with men 2a and fmtc Hum Mol Genet 2 851 6
25. Y Cohen M Xing E Mambo Z Guo G Wu B Trink U Beller WH Westra PW Ladenson D Sidransky 2003 Braf mutation in papillary thyroid carcinoma J Natl Cancer Inst 95 625 7
26. ET Kimura MN Nikiforova Z Zhu JA Knauf YE Nikiforov JA Fagin 2003 High prevalence of braf mutations in thyroid cancer: genetic evidence for constitutive activation of the ret/ptc-ras-braf signaling pathway in papillary thyroid carcinoma Cancer Res 63 1454 7
27. MN Nikiforova ET Kimura M Gandhi PW Biddinger JA Knauf F Basolo Z Zhu R Giannini G Salvatore A Fusco M Santoro JA Fagin YE Nikiforov 2003 Braf mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas J Clin Endocrinol Metab 88 5399 404
28. M Xing WH Westra RP Tufano Y Cohen E Rosenbaum KJ Rhoden KA Carson V Vasko A Larin G Tallini S Tolaney EH Holt P Hui CB Umbricht S Basaria M Ewertz AP Tufaro JA Califano MD Ringel MA Zeiger D Sidransky PW Ladenson 2005 Braf mutation predicts a poorer clinical prognosis for papillary thyroid cancer J Clin Endocrinol Metab 90 6373 9
29. H Namba M Nakashima T Hayashi N Hayashida S Maeda TI Rogounovitch A Ohtsuru VA Saenko T Kanematsu S Yamashita 2003 Clinical implication of hot spot braf mutation, v599e, in papillary thyroid cancers J Clin Endocrinol Metab 88 4393 7
30. PA Wright NR Lemoine ES Mayall FS Wyllie D Hughes ED Williams D Wynford-Thomas 1989 Papillary and follicular thyroid carcinomas show a different pattern of ras oncogene mutation Br J Cancer 60 576 7
31. H Namba SA Rubin JA Fagin 1990 Point mutations of ras oncogenes are an early event in thyroid tumorigenesis Mol Endocrinol 4 1474 9
32. NR Lemoine ES Mayall FS Wyllie ED Williams M Goyns B Stringer D Wynford-Thomas 1989 High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis Oncogene 4 159 64
33. V Vasko M Ferrand J Di Cristofaro P Carayon JF Henry C de Micco 2003 Specific pattern of ras oncogene mutations in follicular thyroid tumors J Clin Endocrinol Metab 88 2745 52
34. TG Kroll P Sarraf L Pecciarini CJ Chen E Mueller BM Spiegelman JA Fletcher 2000 Pax8-pparγ1 fusion oncogene in human thyroid carcinoma [corrected] Science 289 1357 60
35. MN Nikiforova RA Lynch PW Biddinger EK Alexander GW Dorn 2nd G Tallini TG Kroll YE Nikiforov 2003 Ras point mutations and pax8-ppar gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma J Clin Endocrinol Metab 88 2318 26
36. F Basolo F Pisaturo LE Pollina G Fontanini R Elisei E Molinaro P Iacconi P Miccoli F Pacini 2000 N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation to thyroglobulin expression Thyroid 10 19 23
37. CA French EK Alexander ES Cibas V Nose J Laguette W Faquin J Garber F Moore Jr. JA Fletcher PR Larsen TG Kroll 2003 Genetic and biological subgroups of low-stage follicular thyroid cancer Am J Pathol 162 1053 60
38. TJ Giordano R Kuick DG Thomas DE Misek M Vinco D Sanders Z Zhu R Ciampi M Roh K Shedden P Gauger G Doherty NW Thompson S Hanash RJ Koenig YE Nikiforov 2005 Molecular classification of papillary thyroid carcinoma: Distinct braf, ras, and ret/ptc mutation-specific gene expression profiles discovered by DNA microarray analysis Oncogene 24 6646 56
39. MR Sapio D Posca A Raggioli A Guerra V Marotta M Deandrea M Motta PP Limone G Troncone A Caleo G Rossi G Fenzi M Vitale 2007 Detection of ret/ptc, trk and braf mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings Clin Endocrinol (Oxf) 66 678 83
40. Y Cohen E Rosenbaum DP Clark MA Zeiger CB Umbricht RP Tufano D Sidransky WH Westra 2004 Mutational analysis of braf in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules Clin Cancer Res 10 2761 5
41. KW Chung SK Yang GK Lee EY Kim S Kwon SH Lee J Park do HS Lee BY Cho ES Lee SW Kim 2006 Detection of brafv600e mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in braf600e mutation-prevalent area Clin Endocrinol (Oxf) 65 660 6
42. G Pizzolanti L Russo P Richiusa V Bronte RB Nuara V Rodolico MC Amato L Smeraldi PS Sisto M Nucera A Bommarito R Citarrella R Lo Coco D Cabibi A Lo Coco F Frasca G Gulotta MA Latteri G Modica A Galluzzo C Giordano 2007 Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through braf v600e mutation and ret/ptc rearrangement Thyroid 17 1109 15
43. CC Cheung B Carydis S Ezzat YC Bedard SL Asa 2001 Analysis of ret/ptc gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer J Clin Endocrinol Metab 86 2187 90
44. L Jin TJ Sebo N Nakamura X Qian A Oliveira JA Majerus MR Johnson RV Lloyd 2006 Braf mutation analysis in fine needle aspiration (fna) cytology of the thyroid Diagn Mol Pathol 15 136 43
45. M Xing RP Tufano AP Tufaro S Basaria M Ewertz E Rosenbaum PJ Byrne J Wang D Sidransky PW Ladenson 2004 Detection of braf mutation on fine needle aspiration biopsy specimens: A new diagnostic tool for papillary thyroid cancer J Clin Endocrinol Metab 89 2867 72
46. G Salvatore R Giannini P Faviana A Caleo I Migliaccio JA Fagin YE Nikiforov G Troncone L Palombini F Basolo M Santoro 2004 Analysis of braf point mutation and ret/ptc rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma J Clin Endocrinol Metab 89 5175 80
47. LR Rowe BG Bentz JS Bentz 2006 Utility of braf v600e mutation detection in cytologically indeterminate thyroid nodules Cytojournal 3 10
48. TJ Giordano AY Au R Kuick DG Thomas DR Rhodes KG Wilhelm Jr. M Vinco DE Misek D Sanders Z Zhu R Ciampi S Hanash A Chinnaiyan RJ Clifton-Bligh BG Robinson YE Nikiforov RJ Koenig 2006 Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the pax8-pparg translocation Clin Cancer Res 12 1983 93
49. WO Lui T Foukakis J Liden SR Thoppe T Dwight A Hoog J Zedenius G Wallin M Reimers C Larsson 2005 Expression profiling reveals a distinct transcription signature in follicular thyroid carcinomas with a pax8-ppar(gamma) fusion oncogene Oncogene 24 1467 76
50. Lui W, Zeng L, Rehrmann V, Deshpande S, Tretiakova M, Kaplan E, Leibiger I, Leibiger B, Enberg U, Hoog A, Larsson C, Kroll T. CREB3L2-PPARγ fusion mutation identifies a thyroid signaling pathway regulated by intramembrane proteolysis. Cancer Res (in press), 2008.
51. J Powell X Wang B Allard M Sahin X-L Wang I Hay H Hiddinga S Desphande T Kroll S Grebe N Eberhardt B McIver 2004 The pax8/pparg fusion oncoprotein transforms immortalized human thyrocytes through a mechanism probably involving wild-type pparg inhibition Oncogene 23 3634 41
52. MN Nikiforova PW Biddinger CM Caudill TG Kroll YE Nikiforov 2002 Pax8-ppargamma rearrangement in thyroid tumors: Rt-pcr and immunohistochemical analyses Am J Surg Pathol 26 1016 23
53. AR Marques C Espadinha AL Catarino S Moniz T Pereira LG Sobrinho V Leite 2002 Expression of pax8-ppargamma1 rearrangements in both follicular thyroid carcinomas and adenomas J Clin Endocrinol Metab 87 3947 52
54. L Lacroix C Mian T Barrier M Talbot B Caillou M Schlumberger JM Bidart 2004 Pax8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malignant thyroid tissues Eur J Endocrinol 151 367 74
55. T Dwight SR Thoppe T Foukakis WO Lui G Wallin A Hoog T Frisk C Larsson J Zedenius 2003 Involvement of the pax8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors J Clin Endocrinol Metab 88 4440 5
56. L Cheung M Messina A Gill A Clarkson D Learoyd L Delbridge J Wentworth J Philips R Clifton-Bligh BG Robinson 2003 Detection of the pax8-ppar gamma fusion oncogene in both follicular thyroid carcinomas and adenomas J Clin Endocrinol Metab 88 354 7
57. L Roque VM Nunes C Ribeiro C Martins J Soares 2001 Karyotypic characterization of papillary thyroid carcinomas Cancer 92 2529 38
58. L Lacroix V Lazar S Michiels H Ripoche P Dessen M Talbot B Caillou JP Levillain M Schlumberger JM Bidart 2005 Follicular thyroid tumors with the pax8-ppargamma1 rearrangement display characteristic genetic alterations Am J Pathol 167 223 31
59. CC Cheung S Ezzat L Ramyar JL Freeman SL Asa 2000 Molecular basis off hurthle cell papillary thyroid carcinoma J Clin Endocrinol Metab 85 878 82
60. G Chiappetta P Toti F Cetta A Giuliano F Pentimalli I Amendola S Lazzi M Monaco L Mazzuchelli P Tosi M Santoro A Fusco 2002 The ret/ptc oncogene is frequently activated in oncocytic thyroid tumors (hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions J Clin Endocrinol Metab 87 364 9
61. G Belchetz CC Cheung J Freeman IB Rosen IJ Witterick SL Asa 2002 Hurthle cell tumors: Using molecular techniques to define a novel classification system Arch Otolaryngol Head Neck Surg 128 237 40
62. MJ van de Vijver YD He LJ van't Veer H Dai AA Hart DW Voskuil GJ Schreiber JL Peterse C Roberts MJ Marton M Parrish D Atsma A Witteveen A Glas L Delahaye T van der Velde H Bartelink S Rodenhuis ET Rutgers SH Friend R Bernards 2002 A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 347 1999 2009
63. CM Perou T Sorlie MB Eisen M van de Rijn SS Jeffrey CA Rees JR Pollack DT Ross H Johnsen LA Akslen O Fluge A Pergamenschikov C Williams SX Zhu PE Lonning AL Borresen-Dale PO Brown D Botstein 2000 Molecular portraits of human breast tumours Nature 406 747 52
64. SA Armstrong JE Staunton LB Silverman R Pieters ML den Boer MD Minden SE Sallan ES Lander TR Golub SJ Korsmeyer 2002 Mll translocations specify a distinct gene expression profile that distinguishes a unique leukemia Nat Genet 30 41 7
65. EJ Yeoh ME Ross SA Shurtleff WK Williams D Patel R Mahfouz FG Behm SC Raimondi MV Relling A Patel C Cheng D Campana D Wilkins X Zhou J Li H Liu CH Pui WE Evans C Naeve L Wong JR Downing 2002 Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling Cancer Cell 1 133 43